Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

42.35 -1.77 (-4.01%)
Official Closing Price Updated: 7:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
43 44 Next >
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Nov. 11-15, 2024. 
Via Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Hims & Hers has given back recent gains, but don't overlook the company's massive growth. 
Via The Motley Fool
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
From Volatility To Opportunity: Key Stocks Poised To Shine Today
Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals. 
Via Talk Markets
Peering Into Hims & Hers Health's Recent Short Interest
 
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
 
Via Benzinga
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing? 
Via Chartmill
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new upfront pricing for telehealth visits and treatment plans. 
Via Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing rising demand and pharmacy shortages. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
From Hims & Hers
Via Business Wire
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
The healthcare company is on fire, and it's still cheap by many measures. 
Via The Motley Fool
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential 
Via MarketBeat
Tesla, Trump Trades, And Tech: Top Stocks To Watch Today
With TSLA pushing for $260 and HIMS at all-time highs, today’s movers are primed for action. Here’s what’s driving these gains. 
Via Talk Markets
Topics Government
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
We Tested Top Stocks; Here’s What’s Best For Your Money
Discover the top-performing stocks with our analysis. In this video, we dive into the Bollinger Band Squeeze strategy while scanning for opportunities. 
Via Talk Markets
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
A Fed rate cut and a slew of big earnings reports filled out a busy week. 
Via Investor's Business Daily
Topics Economy Government
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers strong performance involves much more than just GLP-1 drugs. 
Via The Motley Fool
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
The company expects to enjoy many GLP-1 tailwinds in 2025. 
Via The Motley Fool
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might still be a buy today. 
Via MarketBeat
Topics ETFs Economy
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What's Going On With Hims & Hers Health Stock Tuesday?
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here's what you need to know. 
Via Benzinga
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
The U.S. stock market experienced a slight downturn on Monday, with the S&P 500 index dipping approximately 0.3%. The Dow Jones Industrial Average fell 0.6% to 41,794.60. 
Via Benzinga
Topics Government Stocks
Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details
Hims & Hers Health reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report. 
Via Benzinga
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
Hims stock jumped late Monday after the online pharmacy beat expectations. 
Via Investor's Business Daily
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.